CST3 and metabolic syndrome: Our findings showed that the metabolic components of abdominal obesity and low HDL cholesterol were determinants of cystatin C, and they were consistent with those of prior studies showing that cystatin C is associated with metabolic syndrome [28, 29], obesity determined by BMI [30–32], and HDL [33].